Lumentum Holdings Inc. — Form 10-Q Summary
Reporting period: The filing covers the quarter ended April 2, 2016, Lumentum’s fiscal 2016 third quarter, and the nine months then ended. The request metadata says “2015 Q3,” but that does not match the filing. The fiscal 2016 quarter included one additional week, so comparisons with the prior-year quarter are not fully like-for-like.
Business context
Lumentum supplies optical and photonic products through its Optical Communications (OpComms) and Commercial Lasers (Lasers) segments. It became independent of Viavi in August 2015; fiscal 2016 results therefore reflect its first year operating as a standalone public company, while prior-period results include Viavi allocations.
Key financial metrics
| Metric | Three months ended April 2, 2016 | Three months ended March 28, 2015 | Nine months ended April 2, 2016 | Nine months ended March 28, 2015 |
|---|---|---|---|---|
| Revenue | $230.4 million | $198.7 million | $661.3 million | $628.2 million |
| Gross profit / margin | $62.8 million / 27.3% | $57.1 million / 28.7% | $197.8 million / 29.9% | $194.3 million / 30.9% |
| Operating income (loss) | $(2.3) million | $(10.8) million | $1.4 million | $(8.8) million |
| Net income (loss) | $(7.6) million | $12.2 million | $(5.0) million | $12.4 million |
| Net income (loss) attributable to common shareholders | $(7.9) million | $12.2 million | $(17.3) million | $12.4 million |
| Operating cash flow | Not provided for the quarter | Not provided for the quarter | $73.5 million | $(3.7) million |
| Capital expenditures | Not provided for the quarter | Not provided for the quarter | $63.4 million | $35.3 million |
- Revenue and segments: Quarterly revenue rose 16.0%, driven mainly by OpComms, up 17.9% to $197.2 million. Lasers revenue increased 5.4% to $33.2 million. For nine months, OpComms rose 8.7% to $560.1 million, while Lasers fell 10.4% to $101.2 million.
- Margins and expenses: Quarterly gross margin fell 1.4 percentage points, principally due to a 3-D sensing product inventory write-off. Nine-month gross margin declined 1.0 point, primarily from lower Lasers margins. Operating expenses were $65.1 million for the quarter and $196.4 million for nine months.
- Tax and earnings comparability: Fiscal 2016 recorded tax provisions of $0.1 million for the quarter and $0.3 million for nine months. Prior-year periods included tax benefits of $23.4 million and $22.0 million, respectively, materially affecting the net-income comparison. The nine-month common-shareholder loss also includes $11.7 million of preferred-stock accretion and $0.6 million of cumulative preferred dividends.
- Cash, liquidity and obligations: Cash and equivalents were $157.2 million at April 2, 2016, versus $14.5 million at June 27, 2015. Current assets were $483.3 million and current liabilities $169.0 million. The filing reports no material off-balance-sheet arrangements. It does not identify conventional borrowings or provide a debt balance; verify the complete filing for debt details.
- Cash generation: Nine-month operating cash flow of $73.5 million was more than offset by $63.4 million of capital spending; financing cash flow was $131.4 million, primarily net transfers from Viavi. The cash increase therefore was not solely generated by operations.
Changes, outlook and notable items
- Management said cash on hand and expected operating cash flows should cover liquidity and capital spending needs for at least the next 12 months. It gave no specific revenue or earnings guidance in the supplied text.
- Management expects continued investment in R&D and said spending may rise in absolute dollars. It also expects international revenue to remain important and be a focus for growth; revenue from outside the U.S. was 87.5% of quarterly revenue and 86.2% of nine-month revenue.
- Inventory write-offs were $9.6 million in the quarter and $10.7 million for nine months, versus $1.4 million and $3.4 million in the prior-year periods. The quarter’s margin was affected by a 3-D sensing inventory write-off; management also cited component quality issues and lower demand as factors behind the nine-month Lasers revenue decline.
- The Series A preferred-stock embedded conversion feature generated a $4.8 million quarterly and $5.0 million nine-month unrealized loss, measured using Level 3 valuation inputs. The preferred stock also creates potential dividends, redemption obligations and possible dilution.
- Purchase obligations totaled $164.4 million, including $81.6 million for inventory; management says most are expected to be fulfilled within one year, and many purchase orders may be cancellable or adjustable under their terms. Operating lease commitments totaled $26.5 million.
- Restructuring charges were $1.8 million for the quarter and $3.9 million for nine months; the company cited workforce and facility actions, including the planned closure of its Bloomfield, Connecticut site. The remaining restructuring accrual was $3.8 million.
- The filing describes immaterial prior-period errors involving stock-based compensation, sales and use tax accruals, and preferred-stock accretion. It says their correction did not materially affect the financial statements.
- Key risks include intense competition and pricing pressure, customer concentration and variable ordering, supplier and contract-manufacturer dependence, manufacturing yield and quality issues, international and foreign-exchange exposure, tax uncertainty, and risks from operating as a newly independent company. Routine legal claims were disclosed; management did not expect them to have a material adverse effect, while noting outcomes are uncertain.
Important facts for investors to verify
- Confirm the reporting period: the filing is for fiscal Q3 2016, ended April 2, 2016, not 2015 Q3.
- Assess the sustainability of revenue growth and gross margins, particularly the impact of inventory write-offs, 3-D sensing, and Lasers demand and quality issues.
- Separate recurring operating cash generation from Viavi-related financing transfers and review the scale and timing of capital spending and purchase obligations.
- Review the Series A preferred-stock terms, derivative valuation assumptions, redemption exposure, dividends and potential common-share dilution.
- Evaluate customer and supplier concentration, international revenue exposure, tax valuation allowances and potential separation-related indemnity obligations.